Pitt Hopkins - TCF4 Familial Mutation
- LIS Mnemonic: MBTCF4PT
Collect
Collect whole blood in a purple top (EDTA) tube.
Volume Required
5 ml
Minimum Required
3 ml
Transport
Refrigerate sample until shipment. Send the sample at room temperature with overnight delivery for receipt Monday through Friday within 24 hours of collection.
Stability
Whole blood can be refrigerated until shipment.
Unacceptable conditions
Heparinized specimens, severely hemolyzed specimens, frozen, clotted or possibly commingled specimens, blood in non-sterile or leaky containers, mislabeled or inappropriately labeled specimens.
Specimen Handling
Do not heat, freeze or centrifuge blood before shipment. Refrigerate sample until shipment.
Days Performed
Mon - Fri 9:00am to 4:00pm
Reported
2 -3 weeks
CPT
81479
Disease Information
Clinical Features:
Pitt Hopkins Syndrome (PTHS) is characterized by severe mental retardation, deep set eyes, broad and beaked nasal bridge, wide mouth, cupid’s bow upper lip, a protruding lower face and intermittent hyperventilation followed by apnea. In addition, patients can show a happy personality, stereotypic movements which in addition to microcephaly, breathing anomalies, mental retardation and seizures resemble the features seen in both Rett and Angelman syndromes. Hirschsprung disease and constipation overlap with features observed in Mowat-Wilson syndrome.
Molecular Genetics:
TCF4 is located on chromosome 18q21.2 and it encodes a member of the bHLH transcription factor family. Missense, splice site, nonsense and large deletions have been identified in the TCF4 gene (Zweier et al. 2007, Zweier et al. 2008).
Test Methods:
Sequence analysis of the mutation previously identified in a family member will be performed.
Detection Rate:
The analytical sensitivity is close to 100% for point mutations by DNA sequencing.
Related Tests:
Sequence and deletion/duplication analysis of MECP2, CDKL5, FOXG1, and UBE3A. Sequence analysis of SLC9A6. Methylation-sensitive PCR for Angelman Syndrome.
Results:
Test results with interpretation will be mailed and/or faxed to the referring physician or laboratory following completion of the test. Additional reports will be provided as requested.
Utility:
The clinical utility of such testing is to support a clinical diagnosis of the disease, facilitate genetic counseling, assess the risk to other first degree relatives and to facilitate testing of at - risk family members.
Remarks
Whole blood in EDTA purple top tubes is the preferred sample. High molecular weight genomic DNA, cheek epithelial cells, or other samples containing DNA may be acceptable. Contact the laboratory for specific instructions regarding such samples before sending the sample.
Contact Us
- (215) 590-8736
- Contact Us Online